Virginia Retirement Systems ET AL lessened its holdings in LivaNova PLC (NASDAQ:LIVN) by 5.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,000 shares of the company’s stock after selling 2,200 shares during the quarter. Virginia Retirement Systems ET AL owned 0.07% of LivaNova worth $2,452,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also made changes to their positions in the company. Airain ltd bought a new position in shares of LivaNova during the 2nd quarter worth $1,449,000. Redmile Group LLC bought a new position in shares of LivaNova during the 2nd quarter worth $12,978,000. Hosking Partners LLP grew its stake in shares of LivaNova by 1.6% during the 2nd quarter. Hosking Partners LLP now owns 188,518 shares of the company’s stock worth $11,539,000 after acquiring an additional 3,048 shares during the period. Russell Investments Group Ltd. bought a new position in shares of LivaNova during the 2nd quarter worth $957,000. Finally, Arizona State Retirement System grew its stake in shares of LivaNova by 1.7% during the 2nd quarter. Arizona State Retirement System now owns 18,300 shares of the company’s stock worth $1,120,000 after acquiring an additional 300 shares during the period. Hedge funds and other institutional investors own 86.07% of the company’s stock.
In other LivaNova news, Director Alfred J. Novak sold 2,000 shares of the firm’s stock in a transaction dated Wednesday, November 22nd. The stock was sold at an average price of $85.77, for a total value of $171,540.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $68.55, for a total value of $68,550.00. Following the completion of the transaction, the director now owns 57,296 shares of the company’s stock, valued at approximately $3,927,640.80. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,830 shares of company stock valued at $557,100. 0.28% of the stock is owned by corporate insiders.
LivaNova PLC (NASDAQ:LIVN) opened at $88.00 on Monday. LivaNova PLC has a 12 month low of $44.56 and a 12 month high of $88.49. The company has a quick ratio of 1.42, a current ratio of 2.03 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $4,242.62, a PE ratio of 25.36, a price-to-earnings-growth ratio of 2.64 and a beta of 0.61.
LivaNova (NASDAQ:LIVN) last issued its earnings results on Thursday, November 2nd. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.76 by $0.17. LivaNova had a return on equity of 9.33% and a net margin of 4.63%. The business had revenue of $309.70 million during the quarter, compared to the consensus estimate of $301.22 million. During the same quarter last year, the company earned $0.78 EPS. The firm’s revenue was up 4.9% compared to the same quarter last year. equities analysts expect that LivaNova PLC will post 3.33 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “LivaNova PLC (LIVN) Holdings Cut by Virginia Retirement Systems ET AL” was reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://www.com-unik.info/2017/12/04/livanova-plc-livn-holdings-cut-by-virginia-retirement-systems-et-al.html.
LivaNova Company Profile
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
What are top analysts saying about LivaNova PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LivaNova PLC and related companies.